Micropharma (intellectual property assets) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Micropharma (intellectual property assets) General Information

Description

Portfolio of intellectual property assets in the probiotic sector. The assets are related to development of the probiotic strain Lactobacillus reuteri NCIMB 30242, which is offered under the mark LRC and the Cardioviva brand of probiotics. It is protected by two families of registered patents.

Contact Information

Website
www.micropharma.net
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Buildings and Property
Other Industries
Food Products
Biotechnology
Acquirer
UAS Laboratories
Primary Office
  • Montreal
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Micropharma (intellectual property assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Micropharma (intellectual property assets)‘s full profile, request access.

Request a free trial

Micropharma (intellectual property assets) Executive Team (1)

Name Title Board Seat Contact Info
Ryan Jones Chief Executive Officer
To view Micropharma (intellectual property assets)’s complete executive team members history, request access »

Micropharma (intellectual property assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Micropharma (intellectual property assets)‘s full profile, request access.

Request a free trial